FDA Adverse Event Injury Summary report: N

OT SELECT SIMPLE METER

MDR report key: 7147197 · Received December 27, 2017

Report

Report Number
3008382007-2017-23731
Event Type
Injury
Date Received
December 27, 2017
Report Date
December 21, 2017
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
RS
Reporter Occupation
OTHER CAREGIVERS

Narratives

Description of Event or Problem · 1

ON (B)(6) 2017, THE PATIENT CONTACTED LIFESCAN (LFS) (B)(4), ALLEGING THAT HER ONETOUCH SELECT SIMPLE METER WAS READING INACCURATELY HIGH COMPARED TO A CALIBRATED LABORATORY DEVICE. THE COMPLAINT WAS CLASSIFIED BASED ON CUSTOMER SERVICE REPRESENTATIVE (CSR) DOCUMENTATION. THE PATIENT REPORTED THAT THEY FIRST BECAME AWARE OF THE METER ISSUE ON THE MORNING OF (B)(6) 2017, REPORTING THAT THEY OBTAINED INACCURATE HIGH RESULTS OF ¿6.9 MMOL/L¿ COMPARED TO ¿3.4 MMOL/L¿ OBTAINED ON THE LABORATORY DEVICE. THE PATIENT STATED THAT THEY MANAGE THEIR DIABETES WITH ORAL MEDICATION, DIET AND EXERCISE, AND THAT IN RESPONSE TO THE ALLEGED HIGH READING, THEY INCREASED THE NORMAL DOSE OF MEDICATION, TAKING 3 METFORMIN TABLETS PER DAY, INSTEAD OF THE NORMAL 1-2 TABLETS. THE PATIENT REPORTED THAT AFTER TAKING THE INCREASED MEDICATION FOR FOUR DAYS, THEY DEVELOPED SYMPTOMS OF ¿WEAK, SWEATY AND VERTIGO¿. IN RESPONSE TO THE SYMPTOMS THEY STOPPED THE EXTRA MEDICATION AND THE SYMPTOMS RESOLVED. DURING TROUBLESHOOTING, THE CSR NOTED THAT THE SUBJECT METER WAS SET TO THE CORRECT UNIT OF MEASURE. IT WAS NOTED THAT THE PATIENT HAD USED AN INCORRECT TESTING METHOD, USING A BORIC ACID SOLUTION FOR CLEANING THE SKIN AREA. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT REPORTEDLY DEVELOPED SYMPTOMS SUGGESTIVE OF A SERIOUS INJURY ADVERSE EVENT AFTER THE ALLEGED PRODUCT ISSUE BEGAN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
926595 OT SELECT SIMPLE METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 4218463

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening